Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva

New England Journal of Medicine

Volumn 335, Issue 8, 1996, Pages 555-561

  Shafritz, Adam B ^a   Shore, Eileen M ^a   Gannon, Francis H ^a   Zasloff, Michael A ^a   Taub, Rebecca ^a   Muenke, Maximilian ^b   Kaplan, Frederick S ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; OSSIFYING MYOSITIS; PRIORITY JOURNAL;

BONE MORPHOGENETIC PROTEINS; CELL LINE; FEMALE; GENE EXPRESSION; GROWTH SUBSTANCES; HUMANS; LYMPHOCYTES; MALE; MYOSITIS OSSIFICANS; PROTEINS; RNA, MESSENGER;

EID: 0029746491     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199608223350804     Document Type: Article

References (39)

1. Cohen RB, Hahn GV, Tabas JA, et al. The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva: a study of forty-four patients. J Bone Joint Surg Am 1993;75:215-9.
2. Connor JM, Skirton H, Lunt PW. A three generation family with fibrodysplasia ossificans progressiva. J Med Genet 1993;30:687-9.
3. Kaplan FS, McCluskey W, Hahn G, Tabas JA, Muenke M, Zasloff MA. Genetic transmission of fibrodysplasia ossificans progressiva: report of a family. J Bone Joint Surg Am 1993;75:1214-20.
4. Rocke DM, Zasloff M, Peeper J, Cohen RB, Kaplan FS. Age- and joint-specific risk of initial heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. Clin Orthop 1994;301:243-8.
5. Connor JM, Evans DA. Fibrodysplasia ossificans progressiva: the clinical features and natural history of 34 patients. J Bone Joint Surg Br 1982;64: 76-83.
6. Kaplan FS, Gannon FH, Shafritz AB, Zasloff MA, Shore EM. Acute lymphocytic infiltration in a very early lesion of fibrodysplasia ossificans progressiva. Calcif Tissue Int (in press). abstract.
7. Kaplan FS, Tabas JA, Gannon FH, Finkel G, Hahn GV, Zasloff MA. The histopathology of fibrodysplasia ossificans progressiva: an endochondral process. J Bone Joint Surg Am 1993;75:220-30.
8. Lanchoney TF, Cohen RB, Rocke DM, Zasloff MA, Kaplan FS. Permanent heterotopic ossification at the injection site after diphtheria-tetanus-pertussis immunizations in children who have fibrodysplasia ossificans progressiva. J Pediatr 1995;126:762-4.
9. Shah PB, Zasloff MA, Drummond D, Kaplan FS. Spinal deformity in patients who have fibrodysplasia ossificans progressiva. J Bone Joint Surg Am 1994;76:1442-50.
10. Kaplan FS, Tabas JA, Zasloff MA. Fibrodysplasia ossificans progressiva: a clue from the fly? Calcif Tissue Int 1990;47:117-25.
11. Janoff HB, Tabas JA, Shore EM, et al. Mild expression of fibrodysplasia ossificans progressiva: a report of 3 cases. J Rheumatol 1995;22: 976-8.
12. Watt JL, Stephen GS. Lymphocyte culture for chromosome analysis. In: Rooney DE, Czepulkowski BH, eds. Human cytogenetics: a practical approach. Oxford, England: IRL Press, 1986:39-55.
13. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: molecular clones and activities. Science 1988;242:1528-34.
14. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
15. Kingsley DM. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 1994;8:133-46.
16. Wang ZQ, Grigoriadis AE, Mohle-Steinlein U, Wagner EF. A novel target cell for c-fos-induced oncogenesis: development of chondrogenic tumours in embryonic stem cell chimeras. EMBO J 1991;10:2437-50.
17. Jabs EW, Muller U, Li X, et al. A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell 1993;75:443-50.
18. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press, 1989.
19. Urist MR. Bone: formation by autoinduction. Science 1965;150:893-9.
20. Jones CM, Lyons KM, Hogan BL. Involvement of bone morphogenetic protein-4 (BMP-4) and Vgr-1 in morphogenesis and neurogenesis in the mouse. Development 1991;111:531-42.
21. Francis PH, Richardson MK, Brickell PM, Tickle C. Bone morphogenetic proteins and a signalling pathway that controls patterning in the developing chick limb. Development 1994;120:209-18.
22. Vainio S, Karavanova I, Jowett A, Thesleff I. Identification of BMP-4 as a signal mediating secondary induction between epithelial and mesenchymal tissues during early tooth development. Cell 1993;75:45-58.
23. Kingsley DM, Bland AE, Grubber JM, et al. The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGF beta superfamily. Cell 1992;71:399-410.
24. Storm EE, Huynh TV, Copeland NG, Jenkins NA, Kingsley DM, Lee SJ. Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily. Nature 1994;368:639-43.
25. Nakase T, Nomura S, Yoshikawa H, et al. Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing. J Bone Miner Res 1994;9:651-9.
26. Bostrom MP, Lane IM, Berberian WS, et al. Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing. J Orthop Res 1995;13:357-67.
27. Johansson BM, Wiles MV Evidence for involvement of activin A and bone morphogenetic protein 4 in mammalian mesoderm and hematopoietic development. Mol Cell Biol 1995;15:141-51.
28. Winnier G, Blessing M, Labosky PA, Hogan BL. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 1995;9:2105-16.
29. Padgett RW, Wozney JM, Gelbart WM. Human BMP sequences can confer normal dorsal-ventral patterning in the Drosophila embryo. Proc Natl Acad Sci USA 1993;90:2905-9.
30. Zecca M, Basler K, Struhl G. Sequential organizing activities of engrailed, hedgehog and decapentaplegic in the Drosophila wing. Development 1995;121:2265-78.
31. Takaoka K, Yoshikawa H, Hashimoto J, Ono K, Matsui M, Nakazato H. Transfilter bone induction by Chinese hamster ovary (CHO) cells transfected by DNA encoding bone morphogenetic protein-4. Clin Orthop 1994;300:269-73.
32. Shimizu K, Yoshikawa H, Matsui M, Masuhara K, Takaoka K. Periosteal and intratumorous bone formation in athymic nude mice by Chinese hamster ovary tumors expressing murine bone morphogenetic protein-4. Clin Orthop 1994;300:274-80.
33. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301-14.
34. Buring K. On the origin of cells in heterotopic bone formation. Clin Orthop 1975;110:293-307.
35. Reddi AH, Cunningham NS. Initiation and promotion of bone differentiation by bone morphogenetic proteins. J Bone Miner Res 1993;8: Suppl 2:S499-S502.
36. Katagiri T, Yamaguchi A, Komaki M, et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 1994;127:1755-66. [Erratum, J Cell Biol 1995;128:713.]
37. Einhorn TA, Majeska RJ, Rush EB, Levine PM, Horowitz MC. The expression of cytokine activity by fracture callus. J Bone Miner Res 1995; 10:1272-81.
38. Brighton CT, Lorich DG, Kupcha R, Reilly TM, Jones AR, Woodbury RA II. The pericyte as a possible osteoblast progenitor cell. Clin Orthop 1992;275:287-99.
39. Liebowitz D, Kieff E. Epstein-Barr virus. In: Roizman B, Whitley RJ, Lopez C, eds. The human herpesviruses. New York: Raven Press, 1993: 107-72.